A Cross-National Comparison of Biosimilars Pricing in Argentina, Australia, Brazil, and Italy.
Fernanda Lacerda da Silva MachadoMartín CañásMartín A UrtasunGustavo H MarínFlavia Caixeta AlbuquerqueLisa PontIrma ConvertinoMarco BonasoMarco TuccoriUrsula KirchmayerLuciane Cruz LopesPublished in: Therapeutic innovation & regulatory science (2024)
The study revealed a marked dispersion in the price's differences between biosimilars and RP across the studied countries. Governments should evaluate whether their policies have been successful in improving affordability of biological therapies.